Literature DB >> 18574116

The prevalence of chlamydial infection in Estonia: a population-based survey.

A Uusküla1, M Kals, K Denks, Uk Nurm, L Kasesalu, J Dehovitz, L A McNutt.   

Abstract

The aim of this study was to estimate the prevalence of Chlamydia trachomatis infection among Estonian men and women by a cross-sectional study based on the screening of a probability sample of the residents of Tartu using participant-collected, mail-delivered testing for C. trachomatis complemented with the self-administered questionnaire. Full participation as defined by returning both the questionnaire and specimen was 34% (n = 479; 95% confidence interval [CI] 32-37%). Study participation was 40% (n = 560; 95% CI 37-43%) for subjects returning either or both the study questionnaire and specimen. After weighing the population distribution, the prevalence estimate for the age group of 18-35 years was 5.4% (95% CI 3.0-7.5%), 6.9% (95% CI 3.6-10.3%) among women and 2.7% (95% CI 0.3-5.0%) among men. The number of sexual partners in the past 12 months was the strongest predictor of infection.

Entities:  

Mesh:

Year:  2008        PMID: 18574116      PMCID: PMC2918246          DOI: 10.1258/ijsa.2008.007325

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  17 in total

1.  A case-control study of beliefs and behaviors associated with sexually transmitted disease occurrence in Estonia.

Authors:  T E Wilson; A Uusküla; J Feldman; S Holman; J Dehovitz
Journal:  Sex Transm Dis       Date:  2001-11       Impact factor: 2.830

Review 2.  Uses and abuses of screening tests.

Authors:  David A Grimes; Kenneth F Schulz
Journal:  Lancet       Date:  2002-03-09       Impact factor: 79.321

Review 3.  Recent trends in the epidemiology of sexually transmitted infections in the European Union.

Authors:  K A Fenton; C M Lowndes
Journal:  Sex Transm Infect       Date:  2004-08       Impact factor: 3.519

Review 4.  Chlamydia trachomatis: time for screening?

Authors:  A Spiliopoulou; V Lakiotis; A Vittoraki; D Zavou; D Mauri
Journal:  Clin Microbiol Infect       Date:  2005-09       Impact factor: 8.067

5.  Do questions on sexual behaviour and the method of sample collection affect participation in a screening programme for asymptomatic Chlamydia trachomatis infections in primary care?

Authors:  Irene G M van Valkengoed; Servaas A Morré; Chris J L M Meijer; Adriaan J C van den Brule; A Joan P Boeke
Journal:  Int J STD AIDS       Date:  2002-01       Impact factor: 1.359

6.  Population-based strategies for outreach screening of urogenital Chlamydia trachomatis infections: a randomized, controlled trial.

Authors:  Berit Andersen; Frede Olesen; Jens K Møller; Lars Østergaard
Journal:  J Infect Dis       Date:  2002-01-03       Impact factor: 5.226

7.  Home screening for chlamydial genital infection: is it acceptable to young men and women?

Authors:  J Stephenson; C Carder; A Copas; A Robinson; G Ridgway; A Haines
Journal:  Sex Transm Infect       Date:  2000-02       Impact factor: 3.519

8.  Population-based outreach for Chlamydia screening in men: results from a randomized trial.

Authors:  Delia Scholes; Fred E Heidrich; Patricia Yarbro; Jeff E Lindenbaum; Jeanne M Marrazzo
Journal:  Sex Transm Dis       Date:  2007-11       Impact factor: 2.830

9.  Opportunistic screening for Chlamydia at a community based contraceptive service for young people.

Authors:  V Moens; G Baruch; P Fearon
Journal:  BMJ       Date:  2003-06-07

10.  Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.

Authors:  D Scholes; A Stergachis; F E Heidrich; H Andrilla; K K Holmes; W E Stamm
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245

View more
  11 in total

1.  The determinants of sexually transmitted infections among reproductive age women in St. Petersburg, Estonia and Finland.

Authors:  Elena Regushevskaya; Tatiana Dubikaytis; Made Laanpere; Minna Nikula; Olga Kuznetsova; Hele Karro; Elina Haavio-Mannila; Elina Hemminki
Journal:  Int J Public Health       Date:  2010-06-30       Impact factor: 3.380

2.  Population-based type-specific prevalence of high-risk human papillomavirus infection in Estonia.

Authors:  Anneli Uusküla; Mart Kals; Liina Kosenkranius; Louise-Anne McNutt; Jack DeHovitz J
Journal:  BMC Infect Dis       Date:  2010-03-11       Impact factor: 3.090

3.  Urine-based testing for Chlamydia trachomatis among young adults in a population-based survey in Croatia: feasibility and prevalence.

Authors:  Ivana Božičević; Ivana Grgić; Snježana Židovec-Lepej; Jurja-Ivana Čakalo; Sanja Belak-Kovačević; Aleksandar Štulhofer; Josip Begovac
Journal:  BMC Public Health       Date:  2011-04-14       Impact factor: 3.295

Review 4.  Genital chlamydia prevalence in Europe and non-European high income countries: systematic review and meta-analysis.

Authors:  Shelagh M Redmond; Karin Alexander-Kisslig; Sarah C Woodhall; Ingrid V F van den Broek; Jan van Bergen; Helen Ward; Anneli Uusküla; Björn Herrmann; Berit Andersen; Hannelore M Götz; Otilia Sfetcu; Nicola Low
Journal:  PLoS One       Date:  2015-01-23       Impact factor: 3.240

5.  Provision of chlamydia testing, and training of primary health care staff about chlamydia testing, across four European countries.

Authors:  Anneli Uusküla; Ellie J Ricketts; Claire Rugman; Ruth R Kalda; Hans Fredlund; Johan Hedlund; Brigitte Dunais; Pia P Touboul; Cliodna McNulty
Journal:  BMC Public Health       Date:  2014-11-05       Impact factor: 3.295

6.  Prevalence of chlamydia among HIV positive and HIV negative patients in the Vhembe District as detected by real time PCR from urine samples.

Authors:  Tshepo Malesela Mafokwane; Amidou Samie
Journal:  BMC Res Notes       Date:  2016-02-16

7.  30 Years on Selected Issues in the Prevention of HIV among Persons Who Inject Drugs.

Authors:  D C Des Jarlais; S Pinkerton; H Hagan; V Guardino; J Feelemyer; H Cooper; A Hatzatkis; A Uuskula
Journal:  Adv Prev Med       Date:  2013-06-12

Review 8.  Home-based chlamydia and gonorrhoea screening: a systematic review of strategies and outcomes.

Authors:  Muhammad S Jamil; Jane S Hocking; Heidi M Bauer; Hammad Ali; Handan Wand; Kirsty Smith; Jennifer Walker; Basil Donovan; John M Kaldor; Rebecca J Guy
Journal:  BMC Public Health       Date:  2013-03-04       Impact factor: 3.295

Review 9.  Socioeconomic factors and other sources of variation in the prevalence of genital chlamydia infections: A systematic review and meta-analysis.

Authors:  Joanna Crichton; Matthew Hickman; Rona Campbell; Harriet Batista-Ferrer; John Macleod
Journal:  BMC Public Health       Date:  2015-07-30       Impact factor: 3.295

Review 10.  Chlamydia prevalence in the general population: is there a sex difference? a systematic review.

Authors:  Patrick W Dielissen; Doreth A M Teunissen; Antoine L M Lagro-Janssen
Journal:  BMC Infect Dis       Date:  2013-11-11       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.